FRENKEL JACOB A 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Apr 8, 2022
Insider Transaction Report
Form 4
FRENKEL JACOB A
Director
Transactions
- Award
Stock Option (right to buy)
2022-04-06+50,000→ 50,000 totalExercise: $0.75Exp: 2032-04-06→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Company's Second Amended and Restated Director Compensation Plan, as amended, this option shall vest and become exercisable in 12 consecutive, equal monthly installments commencing on May 6, 2022 until fully vested and exercisable on the 12 month anniversary of April 6, 2022, provided that the Reporting Person remains a member of the Board of Directors of the Issuer on each vesting date.